Scientific advisers to the C.D.C. have been discussing the details of federal guidance on who qualifies for a Pfizer-BioNTech booster shot and why. A decision is expected on Thursday.
Published: September 23, 2021 at 10:59AM
from NYT Health https://ift.tt/3zAx3zp